303225-22-1 Usage
Uses
Used in Organic Synthesis:
4-(Chloromethyl)-3-(2,6-dichlorophenyl)-5-Methylisoxazole is used as a chemical intermediate for the synthesis of more complex organic compounds. Its unique structure, including the chloromethyl and dichlorophenyl groups, allows for various chemical reactions and modifications, making it a valuable component in the development of new molecules with specific properties.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 4-(Chloromethyl)-3-(2,6-dichlorophenyl)-5-Methylisoxazole may be used as a building block for the creation of new drug candidates. Its structural features could potentially contribute to the development of novel therapeutic agents, particularly in the areas of medicinal chemistry and drug design, where its reactivity and functional groups can be exploited to produce molecules with desired pharmacological properties.
Used in Chemical Research:
4-(Chloromethyl)-3-(2,6-dichlorophenyl)-5-Methylisoxazole is also used in chemical research as a subject of study for understanding its properties, reactivity, and potential applications. Researchers may investigate its behavior in various chemical reactions, its stability under different conditions, and its interactions with other molecules, which could lead to the discovery of new applications and uses in various fields.
Check Digit Verification of cas no
The CAS Registry Mumber 303225-22-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,0,3,2,2 and 5 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 303225-22:
(8*3)+(7*0)+(6*3)+(5*2)+(4*2)+(3*5)+(2*2)+(1*2)=81
81 % 10 = 1
So 303225-22-1 is a valid CAS Registry Number.
InChI:InChI=1/C11H8Cl3NO/c1-6-7(5-12)11(15-16-6)10-8(13)3-2-4-9(10)14/h2-4H,5H2,1H3
303225-22-1Relevant articles and documents
3,4,5-Trisubstituted isoxazoles as novel PPARδ agonists: Part 1
Epple, Robert,Russo, Ross,Azimioara, Mihai,Cow, Christopher,Xie, Yongping,Wang, Xing,Wityak, John,Karanewsky, Don,Gerken, Andrea,Iskandar, Maya,Saez, Enrique,Martin Seidel,Tian, Shin-Shay
, p. 4376 - 4380 (2007/10/03)
We report the identification of a novel series of trisubstituted isoxazoles as PPAR activators from a high-throughput screen. A series of structural optimizations led to improved efficacy and excellent functional receptor selectivity for PPARδ. The isoxazoles represent a series of agonists which display a scaffold that lies outside the typical PPAR agonist motif.
COMPOUNDS AND COMPOSITIONS AS PPAR MODULATORS
-
Page/Page column 21-22, (2010/02/14)
The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of the Peroxisome Proliferator-Activated Receptor (PPAR) families, particularly the activity of PPAR .